Sequus Pharmaceuticals, Inc.
Records under this name other than patents Sequus Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Sequus Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,316,024 | Therapeutic liposome composition and method of preparation Term ended Term ended Mar 2, 2020 · From the USPTO record | Term ended | Term ended Mar 2, 2020 | From the USPTO record |
| US 6,126,966 | Liposomes containing a cisplatin compound Term ended Term ended Jun 29, 2019 · From the USPTO record | Term ended | Term ended Jun 29, 2019 | From the USPTO record |
| US 6,224,903 | Polymer-lipid conjugate for fusion of target membranes Formerly held Term ended Term ended Dec 10, 2018 · From the USPTO record | Term ended | Term ended Dec 10, 2018 | From the USPTO record |
| US 6,326,353 | Enhanced circulation effector composition and method Term ended Term ended Dec 4, 2018 · From the USPTO record | Term ended | Term ended Dec 4, 2018 | From the USPTO record |
| US 6,051,251 | Liposome loading method using a boronic acid compound Term ended Term ended Nov 19, 2018 · From the USPTO record | Term ended | Term ended Nov 19, 2018 | From the USPTO record |
| US 6,133,026 | Condensed plasmid-liposome complex for transfection Term ended Term ended Sep 11, 2018 · From the USPTO record | Term ended | Term ended Sep 11, 2018 | From the USPTO record |
| US 6,056,973 | Therapeutic liposome composition and method of preparation Term ended Term ended Aug 21, 2018 · From the USPTO record | Term ended | Term ended Aug 21, 2018 | From the USPTO record |
| US 6,180,134 | Enhanced ciruclation effector composition and method Term ended Term ended Jan 30, 2018 · From the USPTO record | Term ended | Term ended Jan 30, 2018 | From the USPTO record |
| US 6,043,094 | Therapeutic liposome composition and method Term ended Term ended Oct 10, 2017 · From the USPTO record | Term ended | Term ended Oct 10, 2017 | From the USPTO record |
| US 4,822,777 | Amphotericin B/cholesterol sulfate composition Formerly held Term ended Term ended no later than Apr 18, 2009 · Low confidence | Term ended | Term ended no later than Apr 18, 2009 | Low confidence |